C.129P2-Ccr2tm1Blck/Biat

Status

Available to order

EMMA IDEM:11133
Citation informationRRID:IMSR_EM:11133 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC.129P2-Ccr2tm1Blck/Biat
Alternative name2-Cd
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolCcr2tm1Blck
Gene/Transgene symbolCcr2

Information from provider

ProviderBruno Luckow
Provider affiliationNephrologisches Zentrum, Arbeitsgruppe Klinische Biochemie, Klinikum der Universitaet Muenchen, Medizinische Klinik und Poliklinik IV
Genetic informationThe chemokine receptor Ccr2 has been inactivated by homologous recombination in ES cells. The mutant mice have been backcrossed to the BALB/c genetic background. The floxed neo selection cassette has been deleted by cre-mediated recombination in backcross generation N10+F3. Contains a functioning autofluorescent EGFP reporter gene.
Phenotypic informationHomozygous:
Homozygous animals appear healthy and fertile and show unchallenged no obvious phenotype. Upregulated in many infectious and inflammatory diseases. Important role in leukocyte chemotaxis and innate immunity.

Heterozygous:
Unknown, but most likely wildtype phenotype
Breeding historyCurrently maintained on the background of BALB/cAnNCrl, N16+F15
References
  • Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.;Pérez de Lema Guillermo, Maier Holger, Franz Tobias J, Escribese Maríia, Chilla Silvia, Segerer Stephan, Camarasa Natalia, Schmid Holger, Banas Bernhard, Kalaydjiev Svetoslav, Busch Dirk H, Pfeffer Klaus, Mampaso Francisco, Schlöndorff Detlef, Luckow Bruno, ;2005;Journal of the American Society of Nephrology : JASN;16;3592-601; 16267157
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisednot known

Information from EMMA

Archiving centreUniversity of Veterinary Medicine, Vienna, Austria
Animals used for archivinghomozygous BALB/c;129P2/OlaHsd males

Disease and phenotype information

IMPC phenotypes (gene matching)
  • decreased lymphocyte cell number / IMPC
  • abnormal heart left ventricle morphology / IMPC
  • decreased monocyte cell number / IMPC
  • increased eosinophil cell number / IMPC
  • increased cardiac muscle contractility / IMPC
  • enlarged heart / IMPC
  • abnormal gait / IMPC
  • decreased neutrophil cell number / IMPC
MGI phenotypes (allele matching)
  • altered response to myocardial infarction / MGI
  • abnormal leukocyte adhesion / MGI
  • abnormal cellular extravasation / MGI
MGI phenotypes (gene matching)
  • abnormal trabecular bone morphology / MGI
  • decreased neutrophil cell number / MGI
  • decreased monocyte cell number / MGI
  • altered response to myocardial infarction / MGI
  • enlarged liver / MGI
  • abnormal spleen morphology / MGI
  • enlarged spleen / MGI
  • weight loss / MGI
  • retinal degeneration / MGI
  • abnormal osteoclast physiology / MGI
  • hepatic necrosis / MGI
  • multifocal hepatic necrosis / MGI
  • liver inflammation / MGI
  • decreased inflammatory response / MGI
  • abnormal glucose homeostasis / MGI
  • abnormal lipid homeostasis / MGI
  • decreased airway responsiveness / MGI
  • increased susceptibility to bacterial infection / MGI
  • increased susceptibility to viral infection / MGI
  • abnormal leukocyte physiology / MGI
  • abnormal macrophage morphology / MGI
  • increased IgG level / MGI
  • alcohol aversion / MGI
  • abnormal monocyte morphology / MGI
  • abnormal immune serum protein physiology / MGI
  • abnormal conditioned taste aversion behavior / MGI
  • increased circulating alanine transaminase level / MGI
  • abnormal cytokine secretion / MGI
  • no phenotypic analysis / MGI
  • abnormal leukocyte migration / MGI
  • decreased tumor growth/size / MGI
  • increased alcohol consumption / MGI
  • decreased alcohol consumption / MGI
  • abnormal leukocyte adhesion / MGI
  • abnormal microglial cell physiology / MGI
  • impaired macrophage chemotaxis / MGI
  • decreased macrophage cell number / MGI
  • increased hepatocyte apoptosis / MGI
  • liver hemorrhage / MGI
  • decreased susceptibility to kidney reperfusion injury / MGI
  • decreased susceptibility to experimental autoimmune encephalomyelitis / MGI
  • abnormal vascular wound healing / MGI
  • abnormal osteoclast cell number / MGI
  • decreased osteoclast cell number / MGI
  • increased eosinophil cell number / MGI
  • increased B cell number / MGI
  • abnormal wound healing / MGI
  • diarrhea / MGI
  • decreased acute inflammation / MGI
  • decreased T cell proliferation / MGI
  • abnormal optic choroid morphology / MGI
  • abnormal retinal pigment epithelium morphology / MGI
  • abnormal Bruch membrane morphology / MGI
  • abnormal cholesterol homeostasis / MGI
  • abnormal renal glomerulus morphology / MGI
  • abnormal podocyte morphology / MGI
  • abnormal Langerhans cell physiology / MGI
  • immune system phenotype / MGI
  • choroidal neovascularization / MGI
  • decreased circulating creatinine level / MGI
  • decreased susceptibility to type I hypersensitivity reaction / MGI
  • retinal deposits / MGI
  • abnormal choriocapillaris morphology / MGI
  • abnormal urine protein level / MGI
  • decreased CD4-positive, alpha beta T cell number / MGI
  • increased CD8-positive, alpha-beta T cell number / MGI
  • increased dendritic cell number / MGI
  • abnormal osteoclast differentiation / MGI
  • retinal photoreceptor degeneration / MGI
  • retinal outer nuclear layer degeneration / MGI
  • increased susceptibility to induced colitis / MGI
  • decreased susceptibility to induced colitis / MGI
  • increased tumor necrosis factor secretion / MGI
  • increased interferon-gamma secretion / MGI
  • decreased interferon-gamma secretion / MGI
  • decreased interleukin-2 secretion / MGI
  • decreased interleukin-6 secretion / MGI
  • abnormal chemokine secretion / MGI
  • decreased common myeloid progenitor cell number / MGI
  • lipofuscinosis / MGI
  • increased physiological sensitivity to xenobiotic / MGI
  • decreased splenocyte proliferation / MGI
  • increased trabecular bone thickness / MGI
  • increased susceptibility to viral infection induced morbidity/mortality / MGI
  • abnormal cellular extravasation / MGI
  • decreased susceptibility to bone fracture / MGI
  • abnormal bone mineral density / MGI
  • abnormal dendritic cell chemotaxis / MGI
  • abnormal macrophage chemotaxis / MGI
  • abnormal bone trabecula morphology / MGI
  • increased trabecular bone volume / MGI
  • increased fluid intake / MGI
  • increased CD11b-high dendritic cell number / MGI
  • decreased CD11b-high dendritic cell number / MGI
  • impaired leukocyte tethering or rolling / MGI

Literature references

  • Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.;Pérez de Lema Guillermo, Maier Holger, Franz Tobias J, Escribese Maríia, Chilla Silvia, Segerer Stephan, Camarasa Natalia, Schmid Holger, Banas Bernhard, Kalaydjiev Svetoslav, Busch Dirk H, Pfeffer Klaus, Mampaso Francisco, Schlöndorff Detlef, Luckow Bruno, ;2005;Journal of the American Society of Nephrology : JASN;16;3592-601; 16267157

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).